Nuclear pharmacy was the first specialty area of pharmacy practice, established by the Board of Pharmaceutical Specialties (BPS) in 1978. Unlike chemotherapy pharmacy, which deals exclusively with cancer-fighting drugs, nuclear pharmacy is concerned with the production and safe use of radioactive drugs, called radiopharmaceuticals, in order to treat a variety of illnesses. For example, one of the most effective treatments for hyperthyroidism—a condition characterized by excessive sweating, weight loss, and nervousness due to an overproduction of the thyroid hormone—is radioactive iodine. When consumed, radioactive iodine causes the thyroid gland to shrink, reducing hormone production.
The nuclear pharmacist serves as a member of a nuclear medicine team and is responsible for securing radioactive material to be used in drug preparation. The bulk of a nuclear pharmacists’ duties lie in preparing, testing, dispensing, and monitoring radiopharmaceuticals. These radiopharmaceuticals have a variety of medical uses, but are most commonly employed for diagnostic purposes. When a radiopharmaceutical is ingested, it is absorbed by a specific, targeted organ. This organ transmits the radioactivity, allowing doctors with special imaging equipment to study the organ’s functioning and detect any anomalies. Nuclear pharmacists maintain an inventory of radiopharmaceuticals, prescribe these drugs to patients, and are consulted in case of any unforeseen reactions. They also contribute to department management.
The Board of Pharmacy Specialists (BPS) is the foremost certification agency for the specialized pharmacological fields. Their mission statement is as follows:
“The Mission of the Board of Pharmacy Specialties is to improve patient care by promoting the recognition and value of specialized training, knowledge, and skills in pharmacy and specialty board certification of pharmacists.”
In addition to the undergraduate and pharmacy college schoolwork required for all pharmacists, board certification for nuclear pharmacy requires 4,000 hours nuclear pharmacy training or experience. This can fulfilled in any of the following ways:
Lastly, candidates must pass the Nuclear Pharmacy Specialty Certification Exam.
Board recertification is required every seven years. This process exists to ensure both the public and the pharmacy community that practitioners undergo periodic evaluation. Nuclear pharmacy recertification has three components:
Nuclear pharmacists work in two primary environments: institutional and commercial. Commercial nuclear pharmacists work in a lab, employed by private companies to produce radiopharmaceuticals that are then delivered to hospitals and clinics. Institutional nuclear pharmacists are linked to hospitals and medical centers, where they receive drugs from commercial pharmacies and prepare them for use. They have direct contact with patients and other medical professionals.
Work behind lead shielded glass in a lab
The average annual salary for a nuclear pharmacist is an estimated $118, 452. This can vary considerably depending on a number of factors, including years of experience, certification, size of clinic or hospital where employed, and leadership role in the pharmacy department. Some nuclear pharmacists earn below $100,000 annually, while a small percentage earns $170,000 or more.